Latanoprost Aurobindo

Latanoprost, the active ingredient in Latanoprost Aurobindo, is a prostaglandin analog presented as a ophthalmic solution for ocular (topical) use. It treats open‑angle glaucoma and ocular hypertension by lowering intra‑ocular pressure. GNH USA supplies Latanoprost Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used to manage elevated intra‑ocular pressure in glaucoma‑related conditions. - Open‑angle glaucoma: reduces intra‑ocular pressure to prevent optic nerve damage. - Ocular hypertension: lowers eye pressure to reduce the risk of developing glaucoma. - Secondary open‑angle glaucoma: decreases pressure when glaucoma is secondary to other ocular conditions.

Latanoprost may cause ocular and peri‑ocular reactions. Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris pigmentation: gradual darkening of the iris. - Eye irritation: transient burning or stinging. Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or anaphylaxis. - Uveitis: inflammation of the uveal tract. - Corneal edema: swelling of the cornea that may affect vision.

Before initiating therapy, consider the following precautions. - Monitor IOP: schedule regular intra‑ocular pressure measurements. - Assess for ocular infection: ensure no active infection before use. - Avoid use in active eye inflammation: contraindicated during uveitis or conjunctivitis. - Caution in hypersensitivity: discontinue if allergic signs appear. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents. Major Interactions (Avoid): - Other prostaglandin analog eye drops: additive risk of ocular hyperemia. - Systemic beta‑blockers: may mask the IOP‑lowering effect of latanoprost. Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce latanoprost efficacy. - Miotic agents (e.g., pilocarpine): may antagonize intra‑ocular pressure reduction. - Systemic antihistamines: possible mild reduction in drug absorption.